TheraCell Announces Delivery Of Over 25,000 Of Its Licensed Bone Fiber Grafts
TheraCell Announces Delivery Of Over 25,000 Of Its Licensed Bone Fiber Grafts Products Have Reached an Annual End Customer Sales Rate Approaching $30M News provided by Share this article Share this article LOS ANGELES, Dec. 17, 2020 /PRNewswire/ -- TheraCell Inc., a leading allograft solution company, today announced that over 25,000 of its licensed demineralized bone fiber products have been delivered by its licensee partners. TheraCell's partners have seen steady double-digit quarter over quarter growth, now representing an annual end customer sales rate approaching $30M. (PRNewsfoto/Ther...